- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00879268
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
April 7, 2009 updated by: Polyak, Maximilian
Phase 1 Study of Liver Machine Preservation With Vasosol Solution
This is a pilot trial of centrifugal machine preservation of donor livers for transplantation using a novel preservation solution.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary/ Solitary Liver Transplant
- Lab MELD<35
- Donor age <65
Exclusion Criteria:
- Donor Liver > 30% Macrosteatosis
- DCD donor liver
- Multi-organ Recipient
- Recipient in ICU
- Retransplant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: James V. Guarrera, M.D., Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2004
Primary Completion (Actual)
February 1, 2008
Study Completion (Actual)
February 1, 2009
Study Registration Dates
First Submitted
April 7, 2009
First Submitted That Met QC Criteria
April 7, 2009
First Posted (Estimate)
April 9, 2009
Study Record Updates
Last Update Posted (Estimate)
April 9, 2009
Last Update Submitted That Met QC Criteria
April 7, 2009
Last Verified
April 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- G030132
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplantation
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
The Hospital for Sick ChildrenCompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCanada
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.Active, not recruitingLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Czechia, France, Germany, Italy, Poland, United Kingdom
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLiver Transplantation | Kidney TransplantationFrance
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Rennes University HospitalCompletedLiver Transplantation | Kidney TransplantationFrance
Clinical Trials on Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
-
Columbia UniversityCompleted
-
TransMedicsMassachusetts General Hospital; University of California, Los Angeles; Columbia... and other collaboratorsCompletedHeart FailureUnited States, United Kingdom, France, Italy
-
XVIVO PerfusionRecruitingLung TransplantUnited States
-
Corporacion Parc TauliUnknown
-
Kurt WeissStryker NordicRecruiting
-
Shanghai Jiao Tong University School of MedicineCompletedLiver Transplantation | Transplant RecipientChina
-
Nanjing Medical UniversityCompletedPain, Postoperative | MastectomyChina
-
Massachusetts Eye and Ear InfirmaryRecruitingFuchs Endothelial Corneal DystrophyUnited States
-
Instituto do Cancer do Estado de São PauloCompletedMagnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries (Magnesium)Pain, PostoperativeBrazil